3,249 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 584 funds opening new positions, 1,250 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,250 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.25%67.22% (+0.97%)

Holders
3,249
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$610M
2 +$609M
3 +$455M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$375M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$323M
Name Holding Trade Value Shares
Change
Change in
Stake
826
$7.44M
827
$7.44M
828
$7.43M
829
$7.39M
830
$7.38M
831
$7.37M
832
$7.36M
833
$7.32M
834
$7.32M
835
$7.3M
836
$7.29M
837
$7.29M
838
$7.28M
839
$7.28M
840
$7.27M
841
$7.25M
842
$7.22M
843
$7.21M
844
$7.21M
845
$7.16M
846
$7.15M
847
$7.13M
848
$7.13M
849
$7.12M
850
$7.12M